Fig. 3: Trend in utilization of haploidentical grafts and umbilical cord blood over time compared to other allogeneic transplants in the Extended Cohort.

The three time periods, pre-study (2010–2012), during study (2013–2018), and post-study (2019–2022), were indicated. Haplo haploidentical graft, UCB umbilical cord blood, MRD HLA-identical siblings and HLA-matched other relatives, MUD HLA-matched unrelated donors, mMUD HLA-mismatched unrelated donors.